Structure-activity relationship of estrogens: receptor affinity and estrogen antagonist activity of certain (E)- and (2)-1,2,3-triaryl-2-propen-2-ones

Abstract
The success of antiestrogen therapy in the treatment of certain hormone-responsive breast cancers has led to a resurgence of interest in the molecules which can prevent estrogens from exercising their full biochemical effects. (E)- and (Z)-1,2,3-triphenyl-2-propen-1-ones and some of their phenolic and alkoxy analogs, substituted at the p-position in one or more of the aromatic rings, with synthesized and assigned geometry on the basis of their spectroscopic data. The structure-activity relationship of the triarylpropenones was studied from the point of view of their estrogen receptor affinity and estrogen agonist and antagonist activities. (E)- as well as (Z)-propenones competed with estradiol for binding with the mouse uterine cytosol receptors, with phenolic analogs usually more potent than the unsubstituted as well as alkoxypropenones. The (E)-propenones, which have now emerged as a new group of estrogen receptor ligands, differed from Z isomers quite markedly in their binding specificities. The uterotrophic and antiuterotrophic assays in immature mice revealed that while some of the compounds were marginally estrogenic, nearly all the isomeric propenones were antiestrogenic to a varying degree.

This publication has 11 references indexed in Scilit: